Recognition of infected cells by natural killer cells

Current Opinion in Immunology

Volumn 16, Issue 1, 2004, Pages 26-33

  Carayannopoulos, Leonidas N ^a   Yokoyama, Wayne M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; APOPTOSIS; CELL KILLING; CELL TYPE; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; HUMORAL IMMUNITY; IMMUNOSTIMULATION; INFLUENZA VIRUS A; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; NATURAL KILLER CELL; PARAINFLUENZA VIRUS 1; PROTEIN MOTIF; RECEPTOR BINDING; REVIEW; TARGET CELL DESTRUCTION; VIRUS CELL INTERACTION;

EID: 1042286467     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2003.11.003     Document Type: Review

References (73)

1. Hammerschmidt R. Phytoalexins: what have we learned after 60 years? Annu. Rev. Phytopathol. 37:1999;285-306.
2. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 55:2001;255-281.
3. Wong P., Pamer E.G. CD8 T cell responses to infectious pathogens. Annu. Rev. Immunol. 21:2003;29-70.
4. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev. Immunol. 3:2003;361-370.
5. Screpanti V., Wallin R.P., Ljunggren H.G., Grandien A. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. J. Immunol. 167:2001;2068-2073.
6. Guidotti L.G., Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:2001;65-91.
7. Malissen B. An evolutionary and structural perspective on T cell antigen receptor function. Immunol. Rev. 191:2003;7-27.
8. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., Biassoni R., Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:2001;197-223.
9. •].
10. •] clarifies the often confusing parallels between the murine and human model systems, and also provides an extensive listing of stimulatory and inhibitory receptors that act via the relevant signaling pathways.
11. Krangel M.S. Gene segment selection in V(D)J recombination: accessibility and beyond. Nat. Immunol. 4:2003;624-630.
12. Moser J.M., Byers A.M., Lukacher A.E. NK cell receptors in antiviral immunity. Curr. Opin. Immunol. 14:2002;509-516.
13. Flynn K.J., Riberdy J.M., Christensen J.P., Altman J.D., Doherty P.C. In vivo proliferation of naive and memory influenza-specific CD8(+) T cells. Proc. Natl. Acad. Sci. U.S.A. 96:1999;8597-8602.
14. Busch D.H., Pilip I.M., Vijh S., Pamer E.G. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity. 8:1998;353-362.
15. McQueen K.L., Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr. Opin. Immunol. 14:2002;615-621.
16. Yokoyama W.M., Plougastel B.F. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3:2003;304-316.
17. Diefenbach A., Jamieson A.M., Liu S.D., Shastri N., Raulet D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:2000;119-126.
18. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress- inducible MICA. Science. 285:1999;727-729.
19. Smith H.R., Chuang H.H., Wang L.L., Salcedo M., Heusel J.W., Yokoyama W.M. Nonstochastic coexpression of activation receptors on murine natural killer cells. J. Exp. Med. 191:2000;1341-1354.
20. Dokun A.O., Kim S., Smith H.R., Kang H.S., Chu D.T., Yokoyama W.M. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2:2001;951-956.
21. Karre K. NK cells, MHC class I molecules and the missing self. Scand. J. Immunol. 55:2002;221-228 This review explains the evolution of the 'missing self' paradigm from the perspective of the investigator who first advanced the concept.
22. Tortorella D., Gewurz B.E., Furman M.H., Schust D.J., Ploegh H.L. Viral subversion of the immune system. Annu. Rev. Immunol. 18:2000;861-926.
23. Biron C.A., Nguyen K.B., Pien G.C. Innate immune responses to LCMV infections: natural killer cells and cytokines. Curr. Top Microbiol. Immunol. 263:2002;7-27.
24. Phillips J.H., Lanier L.L. Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J. Exp. Med. 164:1986;814-825.
25. Ortaldo J.R., Young H.A. Expression of IFN-gamma upon triggering of activating Ly49D NK receptors in vitro and in vivo: costimulation with IL-12 or IL-18 overrides inhibitory receptors. J. Immunol. 170:2003;1763-1769.
26. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., Davis D.M., Strominger J.L., Yewdell J.W., Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature. 409:2001;1055-1060.
27. Arnon T.I., Lev M., Katz G., Chernobrov Y., Porgador A., Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 31:2001;2680-2689.
28. Scalzo A.A., Fitzgerald N.A., Wallace C.R., Gibbons A.E., Smart Y.C., Burton R.C., Shellam G.R. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J. Immunol. 149:1992;581-589.
29. Allan J.E., Shellam G.R. Genetic control of murine cytomegalovirus infection: virus titers in resistant and susceptible strains of mice. Arch. Virol. 81:1984;139-150.
30. Lathbury L.J., Allan J.E., Shellam G.R., Scalzo A.A. Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection. J. Gen. Virol. 77:1996;2605-2613.
31. Brown M.G., Dokun A.O., Heusel J.W., Smith H.R., Beckman D.L., Blattenberger E.A., Dubbelde C.E., Stone L.R., Scalzo A.A., Yokoyama W.M. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science. 292:2001;934-937.
32. Daniels K.A., Devora G., Lai W.C., O'Donnell C.L., Bennett M., Welsh R.M. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to ly49h. J. Exp. Med. 194:2001;29-44.
33. Lee S.H., Girard S., Macina D., Busa M., Zafer A., Belouchi A., Gros P., Vidal S.M. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28:2001;42-45.
34. •].
35. •] further support the role of Ly49H as an NK cell activating receptor involved in the recognition of MCMV-infected cells.
36. •].
37. •] discuss activating Ly49 receptors that interact with xenogeneic classical MHC-I and allogeneic nonclassical MHC-I molecules, respectively. It is possible that this recognition of foreign MHC-I molecules represents a cross-reaction. Hypothetically, the 'true ligands' that select for activating Ly49 molecules are MHC-I-like molecules encoded by pathogens (e.g. the MCMV m157 protein).
38. Iizuka K., Naidenko O.V., Plougastel B.F., Fremont D.H., Yokoyama W.M. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat. Immunol. 4:2003;801-807 'The exception that proves the rule' - the authors present the first example of a non-MHC-I-like ligand for an NK C-type-lectin-like receptor.
39. ••].
40. + NK cells.
41. Nguyen K.B., Salazar-Mather T.P., Dalod M.Y., Van Deusen J.B., Wei X.Q., Liew F.Y., Caligiuri M.A., Durbin J.E., Biron C.A. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169:2002;4279-4287 The authors demonstrate the complex effects of innate cytokines on NK activation during in vivo MCMV infection. Specifically, different cytokines activate different NK functions against MCMV.
42. Pien G.C., Satoskar A.R., Takeda K., Akira S., Biron C.A. Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J. Immunol. 165:2000;4787-4791.
43. Andrews D.M., Scalzo A.A., Yokoyama W.M., Smyth M.J., Degli-Esposti M.A. Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 4:2003;175-181 The authors provide in vivo evidence that pathogen-specific NK expansion, mediated by the interaction between an NK receptor (Ly49H) and its pathogen-encoded ligand, is dependent on innate cytokines and dendritic cells.
44. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nature Reviews Immunol. 3:2003;781-790.
45. Ho E.L., Carayannopoulos L.N., Poursine-Laurent J., Kinder J., Plougastel B., Smith H.R.C., Yokoyama W.M. Co-stimulation of multiple NK cell activation receptors by NKG2D. J. Immunol. 169:2002;3667-3675.
46. •].
47. •].
48. •].
49. •] suggest that complex target-cell factors may influence NKG2D-mediated killing.
50. McFarland B.J., Kortemme T., Yu S.F., Baker D., Strong R.K. Symmetry recognizing asymmetry. Analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligands. Structure (Camb.). 11:2003;411-422.
51. Carayannopoulos L., Naidenko O., Fremont D., Yokoyama W.M. Cutting edge: Murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for Murine NKG2D. J. Immunol. 169:2002;4079-4083.
52. Diefenbach A., Hsia J.K., Hsiung M.Y., Raulet D.H. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur. J. Immunol. 33:2003;381-391.
53. Jan Chalupny N., Sutherland C.L., Lawrence W.A., Rein-Weston A., Cosman D. ULBP4 is a novel ligand for human NKG2D. Biochem. Biophys. Res. Commun. 305:2003;129-135.
54. Das H., Groh V., Kuijl C., Sugita M., Morita C.T., Spies T., Bukowski J.F. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity. 15:2001;83-93.
55. Tieng V., Le Bouguenec C., du Merle L., Bertheau P., Desreumaux P., Janin A., Charron D., Toubert A. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc. Natl. Acad. Sci. U.S.A. 99:2002;2977-2982.
56. ••].
57. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., Spies T. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:2001;255-260.
58. Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., Kubin M., Chalupny N.J. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 14:2001;123-133.
59. ••] illustrates the effect of the MCMV anti-NKG2D countermeasure protein UL16 on NKG2D ligand expression and NKG2D-mediated function. It also suggests that MICA and ULBP3 have evolved as counter-countermeasures.
60. ••].
61. ••] shows that gp40 can downregulate surface expression of RAE1, despite the MCMV-induced upregulation of RAE1 mRNA.
62. Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity. 10:1999;661-671.
63. Williams M., Roeth J.F., Kasper M.R., Fleis R.I., Przybycin C.G., Collins K.L. Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking. J. Virol. 76:2002;12173-12184.
64. Ishido S., Wang C., Lee B.S., Cohen G.B., Jung J.U. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74:2000;5300-5309.
65. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. U.S.A. 95:1998;5199-5204.
66. Zhu H., Cong J.P., Mamtora G., Gingeras T., Shenk T. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 95:1998;14470-14475.
67. Ulbrecht M., Martinozzi S., Grzeschik M., Hengel H., Ellwart J.W., Pla M., Weiss E.H. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol. 164:2000;5019-5022.
68. Wang E.C., McSharry B., Retiere C., Tomasec P., Williams S., Borysiewicz L.K., Braud V.M., Wilkinson G.W. UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 99:2002;7570-7575 The authors demonstrate an indirect method by which human CMV can increase cell-surface expression of a ligand for inhibitory NK receptors, resulting in NK-cell inhibition during infection.
69. Michaelsson J., Teixeira de Matos C., Achour A., Lanier L.L., Karre K., Soderstrom K. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J. Exp. Med. 196:2002;1403-1414 This work and the accompanying editorial demonstrate a completely novel means by which a stressed cell might decrease its expression of inhibitory ligands for NK receptors.
70. Arnon TI, Achdout H, Lieberman N, Gazit R, Gonen-Gross T, Katz G, Bar-Ilan A, Bloushtain N, Lev M, Joseph A et al.: The mechanisms controlling the recognition of tumor and virus infected cells by NKp46. Blood 2003 (published online 22 September 2003). DOI: 10.1182/blood-2003-05-1716 .
71. Foster C.E., Colonna M., Sun P.D. Crystal structure of the human NK cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptors. J. Biol. Chem. 278:2003;46081-46086.
72. Davies A., Kalb S., Liang C.J., Lemmonier F.A., Jiang H., Cotter R., Soloski M.J. A peptide from heat shock protein 60 is the dominant peptide bound to Qa-1 in the absence of the MHC class Ia leader dequence Qdm. J. Immunol. 170:2003;5027-5033.
73. Gays F., Fraser K.P., Toomey J.A., Diamond A.G., Millrain M.M., Dyson P.J., Brooks C.G. Functional analysis of the molecular factors controlling Qa1-mediated protection of target cells from NK cells. J. Immunol. 166:2001;1601-1610.